Search

Yun H. Lee

Examiner (ID: 7036)

Most Active Art Unit
3766
Art Unit(s)
3766
Total Applications
267
Issued Applications
215
Pending Applications
3
Abandoned Applications
49

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18057963 [patent_doc_number] => 20220389049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => REVERSIBLE TERMINATORS FOR DNA SEQUENCING AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/815725 [patent_app_country] => US [patent_app_date] => 2022-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18491 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17815725 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/815725
REVERSIBLE TERMINATORS FOR DNA SEQUENCING AND METHODS OF USING THE SAME Jul 27, 2022 Pending
Array ( [id] => 19490522 [patent_doc_number] => 12109206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-08 [patent_title] => Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders [patent_app_type] => utility [patent_app_number] => 17/872575 [patent_app_country] => US [patent_app_date] => 2022-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7397 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17872575 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/872575
Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders Jul 24, 2022 Issued
Array ( [id] => 18226788 [patent_doc_number] => 20230065782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES [patent_app_type] => utility [patent_app_number] => 17/812657 [patent_app_country] => US [patent_app_date] => 2022-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57654 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812657 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/812657
TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES Jul 13, 2022 Pending
Array ( [id] => 19188155 [patent_doc_number] => 20240167068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => METHOD FOR RNA MANUFACTURING [patent_app_type] => utility [patent_app_number] => 18/569372 [patent_app_country] => US [patent_app_date] => 2022-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5395 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569372 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/569372
METHOD FOR RNA MANUFACTURING Jun 29, 2022 Pending
Array ( [id] => 19896912 [patent_doc_number] => 12274808 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-15 [patent_title] => Collagen-based therapeutic delivery systems [patent_app_type] => utility [patent_app_number] => 17/854139 [patent_app_country] => US [patent_app_date] => 2022-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 10998 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17854139 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/854139
Collagen-based therapeutic delivery systems Jun 29, 2022 Issued
Array ( [id] => 19418797 [patent_doc_number] => 20240294920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => MODULATION OF NOX4 EXPRESSION [patent_app_type] => utility [patent_app_number] => 18/569084 [patent_app_country] => US [patent_app_date] => 2022-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30706 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -49 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569084 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/569084
MODULATION OF NOX4 EXPRESSION Jun 29, 2022 Pending
Array ( [id] => 17958569 [patent_doc_number] => 20220339149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => PALONOSETRON FORMULATIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/851017 [patent_app_country] => US [patent_app_date] => 2022-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11830 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851017 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/851017
PALONOSETRON FORMULATIONS AND USES THEREOF Jun 26, 2022 Abandoned
Array ( [id] => 18364655 [patent_doc_number] => 20230146246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => Method of Modulating the Number and the Distribution of Tumor-Infiltrating Leukocytes in Tumors [patent_app_type] => utility [patent_app_number] => 17/844037 [patent_app_country] => US [patent_app_date] => 2022-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36366 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17844037 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/844037
Method of Modulating the Number and the Distribution of Tumor-Infiltrating Leukocytes in Tumors Jun 18, 2022 Pending
Array ( [id] => 19404008 [patent_doc_number] => 20240287519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => TREATMENT OF DKK2 RELATED DISEASES AND DISORDERS [patent_app_type] => utility [patent_app_number] => 18/569113 [patent_app_country] => US [patent_app_date] => 2022-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68260 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569113 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/569113
TREATMENT OF DKK2 RELATED DISEASES AND DISORDERS Jun 16, 2022 Pending
Array ( [id] => 19402289 [patent_doc_number] => 20240285800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => Retinal Disorders [patent_app_type] => utility [patent_app_number] => 18/570701 [patent_app_country] => US [patent_app_date] => 2022-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21119 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570701 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/570701
Retinal Disorders Jun 16, 2022 Pending
Array ( [id] => 17911197 [patent_doc_number] => 20220313592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => Liquid Thickener Composition Comprising Polyalkoxylated [patent_app_type] => utility [patent_app_number] => 17/838499 [patent_app_country] => US [patent_app_date] => 2022-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8659 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 330 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838499 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/838499
Liquid Thickener Composition Comprising Polyalkoxylated Jun 12, 2022 Abandoned
Array ( [id] => 17911198 [patent_doc_number] => 20220313593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => Topical preparations comprising polyalkoxylated polyols polyester [patent_app_type] => utility [patent_app_number] => 17/838503 [patent_app_country] => US [patent_app_date] => 2022-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6434 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838503 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/838503
Topical preparations comprising polyalkoxylated polyols polyester Jun 12, 2022 Abandoned
Array ( [id] => 19777384 [patent_doc_number] => 12226404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-18 [patent_title] => Methods for making compositions for pulmonary administration [patent_app_type] => utility [patent_app_number] => 17/836067 [patent_app_country] => US [patent_app_date] => 2022-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 15 [patent_no_of_words] => 13430 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836067 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/836067
Methods for making compositions for pulmonary administration Jun 8, 2022 Issued
Array ( [id] => 18178692 [patent_doc_number] => 20230039421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => RESIDENCE STRUCTURES AND RELATED METHODS [patent_app_type] => utility [patent_app_number] => 17/836972 [patent_app_country] => US [patent_app_date] => 2022-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836972 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/836972
RESIDENCE STRUCTURES AND RELATED METHODS Jun 8, 2022 Pending
Array ( [id] => 18716491 [patent_doc_number] => 11793813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-24 [patent_title] => Pemetrexed formulations [patent_app_type] => utility [patent_app_number] => 17/835236 [patent_app_country] => US [patent_app_date] => 2022-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 9355 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835236 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/835236
Pemetrexed formulations Jun 7, 2022 Issued
Array ( [id] => 19497921 [patent_doc_number] => 20240336939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => CRISPR INDUCED DISRUPTION OF MOGS GENE [patent_app_type] => utility [patent_app_number] => 18/566446 [patent_app_country] => US [patent_app_date] => 2022-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18529 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18566446 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/566446
CRISPR INDUCED DISRUPTION OF MOGS GENE Jun 1, 2022 Pending
Array ( [id] => 20179739 [patent_doc_number] => 20250263697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => COMPOSITIONS AND METHODS OF MODULATING RNA AND PROTEIN INTERACTIONS [patent_app_type] => utility [patent_app_number] => 18/565689 [patent_app_country] => US [patent_app_date] => 2022-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13903 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18565689 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/565689
COMPOSITIONS AND METHODS OF MODULATING RNA AND PROTEIN INTERACTIONS May 31, 2022 Pending
Array ( [id] => 19684365 [patent_doc_number] => 20250002910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-02 [patent_title] => TREATMENT OF COMPLEMENT-MEDIATED DISORDERS [patent_app_type] => utility [patent_app_number] => 18/563184 [patent_app_country] => US [patent_app_date] => 2022-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45865 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563184 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/563184
TREATMENT OF COMPLEMENT-MEDIATED DISORDERS May 25, 2022 Pending
Array ( [id] => 19318647 [patent_doc_number] => 20240240190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => INHIBITORS OF MITOFERRIN-2 FOR USE IN TREATING CANCER [patent_app_type] => utility [patent_app_number] => 18/562167 [patent_app_country] => US [patent_app_date] => 2022-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12584 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562167 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/562167
INHIBITORS OF MITOFERRIN-2 FOR USE IN TREATING CANCER May 19, 2022 Pending
Array ( [id] => 18270810 [patent_doc_number] => 20230092052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => INTERPENETRATING NETWORK HYDROGELS WITH INDEPENDENTLY TUNABLE STIFFNESS [patent_app_type] => utility [patent_app_number] => 17/748330 [patent_app_country] => US [patent_app_date] => 2022-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17782 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748330 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/748330
INTERPENETRATING NETWORK HYDROGELS WITH INDEPENDENTLY TUNABLE STIFFNESS May 18, 2022 Abandoned
Menu